187 related articles for article (PubMed ID: 22614206)
21. [Evaluation of bone scintigraphy and (18)F-FDG PET/CT in bone metastases of lung cancer patients].
Portilla-Quattrociocchi H; Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; de Arcocha Torres M; Medina-Quiroz P; del Castillo R; Rubio-Vassallo A; Carril JM
Rev Esp Med Nucl; 2011; 30(1):2-7. PubMed ID: 21208693
[TBL] [Abstract][Full Text] [Related]
22. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
[TBL] [Abstract][Full Text] [Related]
23. A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT.
Erhamamci S; Reyhan M; Canpolat T; Nursal GN; Yapar AF
Clin Nucl Med; 2016 Mar; 41(3):e146-8. PubMed ID: 26562574
[TBL] [Abstract][Full Text] [Related]
24. 18F-FDG PET/CT demonstrating response to targeted therapy in synchronous metastatic adenocarcinoma of the lung and poorly differentiated carcinoma of the thyroid.
Kumar NS; Basu S
Natl Med J India; 2015; 28(3):155. PubMed ID: 26724353
[No Abstract] [Full Text] [Related]
25. (18)F-FDG PET/CT and (99m)Tc-MDP imaging of non-small cell lung carcinoma osseous metastases.
Komissarova M; Wong KK; Fig LM
J Nucl Med Technol; 2012 Mar; 40(1):66-7, 70. PubMed ID: 22279236
[No Abstract] [Full Text] [Related]
26. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Ng SP; David S; Alamgeer M; Ganju V
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of dual-time
Pahk K; Chung JH; Kim S; Lee SH
Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
[TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
29. Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma.
Sasada S; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Okada M
Ann Thorac Surg; 2014 Aug; 98(2):417-22. PubMed ID: 24961842
[TBL] [Abstract][Full Text] [Related]
30. Radiation-induced osteosarcoma might mimic metastatic bone lesions: a case with bone scan and FDG PET/CT imaging.
Koyama M; Koizumi M; Umayahara K; Takeshima N; Takahashi S
Clin Nucl Med; 2015 May; 40(5):427-9. PubMed ID: 25608153
[TBL] [Abstract][Full Text] [Related]
31. Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT.
Mojtahedi A; Solomon SB; Ulaner GA
Clin Nucl Med; 2013 Mar; 38(3):217-8. PubMed ID: 23357824
[TBL] [Abstract][Full Text] [Related]
32. Gelatinous degeneration of the bone marrow mimicking osseous metastasis on 18F-FDG PET/CT.
Chong A; Song HC; Oh JR; Ha JM; Min JJ; Bom HS; Choi YD; Lee JS
Clin Nucl Med; 2012 Aug; 37(8):798-800. PubMed ID: 22785516
[TBL] [Abstract][Full Text] [Related]
33. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
34. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
35. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of synchronous isolated splenic metastasis from lung adenocarcinoma: complementary role of FDG PET/CT and diffusion-weighted MRI.
Soussan M; Pop G; Ouvrier MJ; Neuman A; Weinmann P
Clin Nucl Med; 2011 Aug; 36(8):707-9. PubMed ID: 21716028
[TBL] [Abstract][Full Text] [Related]
37. FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.
Koolen BB; Vegt E; Rutgers EJ; Vogel WV; Stokkel MP; Hoefnagel CA; Fioole-Bruining A; Vrancken Peeters MJ; Valdés Olmos RA
Ann Nucl Med; 2012 Jan; 26(1):86-91. PubMed ID: 21953212
[TBL] [Abstract][Full Text] [Related]
38. Incidental finding of silent appendicitis on (18)F-FDG PET/CT in a patient with small cell lung adenocarcinoma.
Bourgeois S; Van Den Berghe I; De Geeter F
Hell J Nucl Med; 2016; 19(2):164-6. PubMed ID: 27331212
[TBL] [Abstract][Full Text] [Related]
39. Serendipitous Discovery of Isolated Gastric Metastases From Adenocarcinoma of the Lung on Staging 18F-FDG PET-CT.
Sharma P; Dwary AD; Khan EM
Clin Nucl Med; 2017 Oct; 42(10):807-808. PubMed ID: 28806259
[TBL] [Abstract][Full Text] [Related]
40. A rare case of urachal mucinous adenocarcinoma detected by 18F-FDG PET/CT.
Li X; Liu S; Yao S; Wang M
Clin Nucl Med; 2015 Mar; 40(3):282-5. PubMed ID: 25608160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
